Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329-Reference-Cited by-同舟云学术

Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329

Published:2014-01-29 Issue:12 Volume:36 Page:1712-1717
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Malhotra Binu¹,Moon James²,Kucuk Omar³,Clark Joseph I.⁴,Urba Susan G.¹,Wolf Gregory T.⁵,Worden Francis P.¹

Affiliation:

1. Department of Hematology Oncology; University of Michigan; Ann Arbor Michigan

2. Southwest Oncology Group Statistical Center; Seattle Washington

3. Department of Hematology-Oncology; Emory Winship Cancer Institute; Atlanta Georgia

4. Loyola University Medical Center; Maywood Illinois

5. Department of Otolaryngology; University of Michigan; Ann Arbor Michigan

Funder

National Cancer Institute, DHHS

Publisher

Wiley

Subject

Otorhinolaryngology

Reference20 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin 2009,2009

2. The expanding role of systemic therapy in head and neck cancer;Cohen;J Clin Oncol,2004

3. Platinum-based chemotherapy plus cetuximab in head and neck cancer;Vermorken;N Engl J Med,2008

4. Single agent paclitaxel in advanced squamous cell head and neck carcinoma;Gebbia;Eur J Cancer,1996

5. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390);Forastiere;Cancer,1998

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives;Frontiers in Oncology;2024-01-04

2. Combination Therapy as a Promising Way to Fight Oral Cancer;Pharmaceutics;2023-06-04

3. Oropharynx und Larynx;Medikamentöse Tumortherapie von Kopf-Hals-Tumoren;2022

4. Role of Systemic Therapy;Management of Oral Cancers;2020-09-09

5. Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database;Clinical Therapeutics;2018-09